Coherus BioSciences Inc (CHRS)
$1.61 -$0.00 (-0.29%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$195.86M -
Day's Range
$1.65 - $1.72 -
Volume
13,551,950 -
52 Week Low / High
$0.66 - $3.70 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 4
- Strong Buy
- 2
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- $12.63
- Target Price
Company News
-
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now — Sep 28th, 2024
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 b...
-
Short Interest Surges to 21.83% as Coherus BioSciences, Inc. (CHRS) Faces Revenue Challenges — Sep 25th, 2024
We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other worst 52-week low stocks to buy now according to short sellers. The U.S...
-
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now — Sep 28th, 2024
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 b...
-
Short Interest Surges to 21.83% as Coherus BioSciences, Inc. (CHRS) Faces Revenue Challenges — Sep 25th, 2024
We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other worst 52-week low stocks to buy now according to short sellers. The U.S...
-
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now — Sep 28th, 2024
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 b...
-
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now — Sep 28th, 2024
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 b...
-
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now — Sep 28th, 2024
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Coherus BioSciences, Inc. (NASDAQ:CHRS) stands against the other Worst 52-Week Low Stocks. The U.S. Federal Reserve conducting a 50 b...
Portfolio
Comprised of 1 portfolios